Related Experiment Video
Updated: Aug 14, 2025
10:17
The Tail Suspension Test
Published on: January 28, 2012
80.6K
Premature Ejaculation after Lithium Treatment in a Patient with Bipolar Disorder
Pedro Amadeu Almeida1, Filipa Caldas1, Inês Homem de Melo1
1Psychiatry Department, Hospital de Magalhães Lemos, Porto, Portugal.
Case Reports in Psychiatry
|January 19, 2023
Summary
Lithium effectively treats bipolar disorder but can cause rare sexual side effects like premature ejaculation. Reducing the lithium dose can resolve this issue, highlighting the need for clinical awareness.
Area of Science:
- Psychiatry
- Pharmacology
- Sexual Medicine
Background:
- Lithium is a first-line treatment for bipolar disorder.
- Known severe side effects include renal and endocrine dysfunction.
- The impact of lithium on sexual function is less understood.
Observation:
- A 33-year-old male with bipolar disorder developed premature ejaculation after short-term lithium use.
- Reducing the lithium dosage led to a rapid resolution of the sexual side effect.
- Lithium-induced premature ejaculation was identified as the most probable diagnosis.
Findings:
- Premature ejaculation is a rare adverse effect associated with lithium treatment.
- Potential management strategies include adjusting medication timing and dosage.
- Altered central nervous system serotonin pathways may underlie this side effect.
Implications:
- Clinicians should proactively inquire about sexual adverse effects in patients on lithium.
- Increased awareness can improve patient care and treatment adherence.
- Further research into lithium's sexual side effects is warranted.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
290
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
290
01:30Bipolar Disorder
118
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
118
01:26Psychosis: Goals of Pharmacotherapy
185
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
185
01:30Electroconvulsive Therapy
109
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
109
01:23Antidepressant Drugs: MAOIs and Other Agents
300
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
300
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
247
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
247